Skip to main content

Day: August 9, 2024

Kalmar Corporation, Managers’ Transactions: Niiranen, Sami

KALMAR CORPORATION, MANAGERS’ TRANSACTIONS, 9 AUGUST 2024 AT 3:00 PM EEST Kalmar Corporation, Managers’ Transactions: Niiranen, Sami ____________________________________________Person subject to the notification requirementName: Sami NiiranenPosition: Chief Executive OfficerIssuer: Kalmar OyjLEI: 636700Z25ZQXLMZ3CY73Notification type: INITIAL NOTIFICATIONReference number: 73945/5/4 ____________________________________________Transaction date: 2024-08-09Venue: NASDAQ HELSINKI LTD (XHEL)Instrument type: SHAREISIN: FI4000571054Nature of transaction: ACQUISITION Transaction details(1): Volume: 5000 Unit price: 25.9082 EUR Aggregated transactions (1):Volume: 5000 Volume weighted average price: 25.9082 EURAdditional information:Carina Geber-Teir, SVP, IR, Marketing & Communications, tel. +358 40 502 4697 Camilla Maikola, Director,...

Continue reading

LGI Homes Opens Two New Communities in the Albuquerque Market

The Bisbee Plan by LGI HomesThe three-bedroom, two-bathroom Bisbee features a wonderful open-concept floor plan and a wonderful covered, outdoor patio.ALBUQUERQUE, N.M., Aug. 09, 2024 (GLOBE NEWSWIRE) — LGI Homes, Inc. (NASDAQ: LGIH) is excited to announce the opening of its latest communities, Villa De Marcos Gabriel and Legacy at Sierra Vista, in the Albuquerque market. These exceptional new neighborhoods offer stunning new construction homes, with prices starting in the low $300s. Villa De Marcos Gabriel is ideally situated in Stinson Tower, providing residents with quick and easy access to a wide array of big-city amenities. This charming community is conveniently located near numerous employers, parks, recreation centers and other local attractions. Legacy at Sierra Vista offers a serene living environment paired...

Continue reading

Dycom Industries, Inc. to Host Fiscal 2025 Second Quarter Results Conference Call

PALM BEACH GARDENS, Fla., Aug. 09, 2024 (GLOBE NEWSWIRE) — Dycom Industries, Inc. (NYSE: DY) will host a conference call to discuss fiscal 2025 second quarter results on Wednesday, August 21, 2024, at 9:00 a.m. ET. Dycom will issue a press release reporting its results earlier that morning. Interested parties may participate in the question and answer session of the conference call by registering at https://register.vevent.com/register/BI792f883035104fca9ba48d0d4da25061. Upon registration, participants will receive a dial-in number and unique PIN to access the call. Participants are encouraged to join approximately ten minutes prior to the scheduled start time. For all other attendees, a live listen-only audio webcast of the call, including an accompanying slide presentation, can be accessed directly at https://edge.media-server.com/mmc/p/rk4t4eoj....

Continue reading

NeurAxis Reports Second Quarter 2024 Financial Results

Conference call will be held today, Friday, August 9 at 9:00 am ET Carmel, Ind., Aug. 09, 2024 (GLOBE NEWSWIRE) — NeurAxis, Inc. (“NeurAxis,” or the “Company”) (NYSE American: NRXS), a medical technology company commercializing neuromodulation therapies for chronic and debilitating conditions in children and adults, today announced results for the second quarter period ended June 30, 2024. Recent Operational HighlightsExpanded total covered lives to approximately 22.5 million covered lives compared to 4.5 million covered lives as of May 1, 2023. Recent medical policy coverages include:BCBS licensee in Florida covering over 6 million lives. BCBS licensee in North Dakota covering over 310,000 people. BCBS plan in the mid-Atlantic region, providing coverage for approximately 7 million covered lives. Medical Policy with a BCBS...

Continue reading

Firm Capital Mortgage Investment Corporation Announces Q2/2024 Results, as Well as the Declaration of October, and November Monthly Cash Dividends

TORONTO, Aug. 09, 2024 (GLOBE NEWSWIRE) — Firm Capital Mortgage Investment Corporation (the “Corporation”) (TSX FC, FC.DB,H, FC.DB.I, FC.DB.J ,FC.DB. K and FC.DB.L) today released its financial statements for the six months ended June 30, 2024. NET INCOMEFor the three months ended June 30, 2024, net income increased by 0.1 % to $8,533,772 as compared to $8,522,355 for the same period in 2023. Net income for the six months ended June 30, 2024 decreased by 0.8% to $17,103,556, as compared to $17,234,251 reported for the same period in 2023. EARNINGS PER SHAREBasic weighted average earnings per share for the three months ended June 30, 2024 was $0.247 (2023 – $0.245). Basic weighted average earnings per share for the six months ended June 30, 2024 was $0.496 (2023 – $0.500). PORTFOLIOThe Corporation’s Investment Portfolio increased...

Continue reading

Hurco Announces Strategic Collaboration with Kawasaki Robotics to Deliver Turnkey, Industrial-Grade, Robotic Machine-Tending Solutions

Companies will present interactive, no-code, turnkey, robotic machine tending demos in booth #236520 and booth #338319 at the 2024 International Manufacturing Technology Show (IMTS) in Chicago, Illinois (USA) INDIANAPOLIS, Aug. 09, 2024 (GLOBE NEWSWIRE) — Hurco Companies, Inc. (Nasdaq: HURC), a premier CNC machine and controls industrial technology company, and Kawasaki Robotics (USA), Inc., a leading manufacturer of industrial robotics and automation systems, announced today the formation of a strategic collaboration aimed at enhancing innovation and delivering industrial-grade robotic CNC machine solutions to their customers. The collaboration will leverage the strengths of both companies, combining 50+ years of Hurco’s CNC machine and controls innovation for short-run manufacturing operations with 50+ years of Kawasaki’s...

Continue reading

LiveOne (NASDAQ: LVO) Announces Total Memberships Surpass 3.9M

– Tesla Membership: Boasts 26% year-over-year growth – New Paid Members: Increase over 225k in Fiscal Year 2025 and an impressive 64K in July 2024 – Total Membership: Grew 23% year-over-year – B2B Pipeline: Expands to 63, including four signed partnerships to be announced upon launch LOS ANGELES, Aug. 09, 2024 (GLOBE NEWSWIRE) — LiveOne (Nasdaq: LVO), an award-winning, creator-first, music, entertainment and technology platform, announced today an update for certain of its July 2024 and fiscal year ending March 31, 2025 (“Fiscal Year 2025”) memberships metrics and its B2B pipeline. Brad Konkol, Head of Slacker Radio, commented, “We are pleased with our continued growth and extremely enthusiastic regarding the strategic vision of Slacker Radio and LiveOne. Our commitment to building strong B2B partnerships...

Continue reading

Sofwave to Participate in 9th Annual Needham Virtual MedTech & Diagnostics Conference

SAN CLEMENTE, Calif., Aug. 09, 2024 (GLOBE NEWSWIRE) — Sofwave Medical Ltd (“the Company”) (TASE: SOFW), an emerging leader in energy-based non-invasive, aesthetic medical devices, today announced that Louis Scafuri, Chief Executive Officer, and Assaf Korner, Chief Financial Officer, will participate in the 9th Annual Needham Virtual MedTech & Diagnostics 1×1 Conference on August 12 – 13, 2024. About Sofwave MedicalSofwave Medical Ltd. has implemented an innovative approach to wrinkle reduction lifting and cellulite using its proprietary breakthrough technology. SUPERB™, Synchronous Ultrasound Parallel Beam technology, is FDA-cleared to improve facial lines and wrinkles, lifting the eyebrow and lifting lax submental tissue (beneath the chin), lifting lax skin in the arms, as well as the short-term improvement in the...

Continue reading

Monopar Therapeutics Reports Second Quarter 2024 Financial Results and Recent Developments

Initiated and Enrolling Patients into MNPR-101-Zr First-in-Human Phase 1 Radiopharma Clinical Trial MNPR-101 radio-immuno-therapeutic (RIT) Clinical Trial on Track to Initiate in Q4 2024 WILMETTE, Ill., Aug. 09, 2024 (GLOBE NEWSWIRE) — Monopar Therapeutics Inc. (Monopar or the Company) (Nasdaq: MNPR), a clinical-stage radiopharmaceutical company focused on developing innovative treatments for cancer patients, today announced second quarter 2024 financial results and summarized recent developments. Recent Developments MNPR-101 for Radiopharmaceutical UseMNPR-101 is a uPAR-targeting antibody being developed as a precision radiopharmaceutical for both imaging and treatment of various cancers.MNPR-101-Zr is a cancer imaging agent radiolabeled with Zirconium-89, a positron emission tomography (PET) imaging isotope. Preclinical...

Continue reading

Urbana Corporation Has Filed 2024 Second Quarter Interim Financial Statements

/NOT FOR DISTRIBUTION TO U.S. WIRE SERVICES OR FOR DISSEMINATION IN THE U.S./ TORONTO, Aug. 09, 2024 (GLOBE NEWSWIRE) — Urbana Corporation (TSX & CSE: URB & URB.A) Urbana Corporation announces today that it has filed its unaudited interim Financial Statements and Management’s Discussion and Analysis for the six-month period ended June 30, 2024 with the applicable Canadian securities regulators. PDF versions of the documents are available at www.urbanacorp.com and at www.sedarplus.ca. For further information contact: Elizabeth Naumovski Investor Relations (416) 595-9106 enaumovski@urbanacorp.com 150 KING ST. W., SUITE 1702, TORONTO, ONTARIO M5H 1J9   TEL: 416-595-9106 FAX: 416-862-2498 www.urbanacorp.com

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Cookie Notice

We use cookies to improve your experience on our website

Information we collect about your use of Goldea Capital website

Goldea Capital website collects personal data about visitors to its website.

When someone visits our websites, we use a third party service, Google Analytics, to collect standard internet log information (such as IP address and type of browser they’re using) and details of visitor behavior patterns. We do this to allow us to keep track of the number of visitors to the various parts of the sites and understand how our website is used. We do not make any attempt to find out the identities or nature of those visiting our websites. We won’t share your information with any other organizations for marketing, market research or commercial purposes and we don’t pass on your details to other websites.

Use of cookies
Cookies are small text files that are placed on your computer or other device by websites that you visit. They are widely used to make websites work, or work more efficiently, as well as to provide information to the owners of the site.